Natural product remedies for COVID-19: A focus on safety

被引:29
作者
Omokhua-Uyi, Aitebiremen Gift [1 ]
Van Staden, Johannes [1 ]
机构
[1] Univ KwaZulu Natal Pietermaritzburg, Sch Life Sci, Res Ctr Plant Growth & Dev, Private Bag X01, ZA-3201 Scottsville, South Africa
关键词
Coronavirus; COVID-19; treatment; Natural products; Safety; Self-medication; Toxicity; ENDOPHYTIC FUNGUS; HERBAL MEDICINES; ADVERSE-REACTIONS; DRUG; SARS-COV-2; ANTIOXIDANT; CELASTROL; TOXICITY; GINSENG; ORIGIN;
D O I
10.1016/j.sajb.2021.03.012
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Infection by the novel coronavirus SARS-CoV-2 causing the coronavirus disease (COVID-19), is currently a global pandemic with more than two million deaths to date. Though a number of vaccines have recently been approved against the virus, availability remains a big challenge, and also acceptance by most people has become a big debate. This review discusses possible/proposed natural product remedies and some major conventional treatment options used to manage the infection and, safety concerns on the use of unproven or unapproved health products against COVID-19. An extensive literature review indicated that the influx of unproven and unapproved health products in the global market are on the rise, leading to various forms of self-medication. To this effect, there have been warnings by the United States Food and Drug Administration and the World Health Organisation against the use of such products. Conventional drugs such as remdesivir, chloroquine/hydroxychloroquine and dexamethasone are the major proposed drugs that are currently undergoing clinical trials for the management of this disease. Efforts are being made globally in the search for possible therapeutics which may be the best way to eradicating this disease. Some countries have approved the use of natural products in the management of COVID-19, despite little or no clinical evidence on their efficacy and safety. Natural products may hold a great potential in the fight against COVID-19 but without detailed clinical trials, their potency against the virus and their safe use cannot be established. To attain this goal, extensive research followed by clinical studies are needed. Collaborative efforts between researchers, clinicians, governments and traditional medicinal practitioners in the search and development of safe and effective therapeutics from natural products for the treatment of COVID-19 could be a potential option. (c) 2021 SAAB. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:386 / 398
页数:13
相关论文
共 143 条
[1]   Bioprospecting of South African Plants as a Unique Resource for Bioactive Endophytic Microbes [J].
Abdalla, Muna Ali ;
McGaw, Lyndy J. .
FRONTIERS IN PHARMACOLOGY, 2018, 9
[2]   SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study [J].
Ahmad, Jamshaid ;
Ikram, Saima ;
Ahmad, Fawad ;
Rehman, Irshad Ur ;
Mushtaq, Maryam .
HELIYON, 2020, 6 (07)
[3]  
Akerele O, 1993, World Health Forum, V14, P390
[4]   COVID-19 Pandemic: A Case for Phytomedicines [J].
Akindele, Abidemi J. ;
Agunbiade, Foluso O. ;
Sofidiya, Margaret O. ;
Awodele, Olufunsho ;
Sowemimo, Abimbola ;
Ade-Ademilua, Omobolanle ;
Akinleye, Moshood O. ;
Ishola, Ismail O. ;
Orabueze, Ifeoma ;
Salu, Olumuyiwa B. ;
Oreagba, Ibrahim A. ;
Asekun, Olayinka T. ;
Odukoya, Olukemi .
NATURAL PRODUCT COMMUNICATIONS, 2020, 15 (08)
[5]  
Alamanou M.T., 2020, ANTICORONAVIRUS NATU
[6]   Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease [J].
Allison, AC ;
Cacabelos, R ;
Lombardi, VRM ;
Alvarez, XA ;
Vigo, C .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2001, 25 (07) :1341-1357
[7]   Exploring the potential of endophytes from medicinal plants as sources of antimycobacterial compounds [J].
Alvin, Alfonsus ;
Miller, Kristin I. ;
Neilan, Brett A. .
MICROBIOLOGICAL RESEARCH, 2014, 169 (7-8) :483-495
[8]   The proximal origin of SARS-CoV-2 [J].
Andersen, Kristian G. ;
Rambaut, Andrew ;
Lipkin, W. Ian ;
Holmes, Edward C. ;
Garry, Robert F. .
NATURE MEDICINE, 2020, 26 (04) :450-452
[9]  
Ang L, 2020, INTEGR MED RES, V9
[10]  
[Anonymous], 2018, WHO Technical Report Series